Markets
5.9
Azul Q3 EBITDA R$1.2B, margin down 13.3pp to 21.4%
Published 1 d ago2 sourcesEvidence: Reported
SeverityModerateInfoMoneyBR
MarketsReportedLow
2.1
Biomm Reverses Loss with R$22.1M Q3 Profit, Confirms 2026 EBITDA Guidance
Brazilian pharma Biomm posted a R$22.1 million net profit in Q3, reversing a prior-year loss, and reaffirmed confidence in hitting the lower end of its 2026 EBITDA guidance, possibly by November. The earnings beat is company-specific and not indicative of a broader sector trend. This is a routine earnings update with limited macro or geopolitical significance.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Score Breakdown
Mosaic Score2.1
Model confidence0.5
Significance0.1
Source credibility0.5
Related signals
8 foundMarkets
2.1
Cemig Q3 profit jumps to R$1.7B, EBITDA R$1.99B
Published 14 h ago1 sourceEvidence: Reported
InfoMoneyBR
Markets
7.9
Brazil's top 4 banks' loan-loss provisions hit record R$49B
Published 1 d ago3 sourcesEvidence: Reported
SeverityHighInfoMoneyBR
Markets
6.8
BTG Pactual Q3 profit hits record R$5.3B, revenue R$10.8B
Published 1 d ago4 sourcesEvidence: Reported
SeverityModeratePoder360Low-rated sourceBR
Markets
6.7
Petrobras Q3 Profit R$39.8B Fails to Halt Share Slide; Support Tested
Published 1 d ago4 sourcesEvidence: Reported
SeverityModerateInfoMoneyBR
Markets
6.4
Nubank Posts $1.09B Q3 Net Profit, Second Straight Quarter Above $1B
Published 1 d ago3 sourcesEvidence: Reported
SeverityModerateInfoMoneyBR
Markets
6.1
Brazilian Retailers Adapt Operations Ahead of 6x1 Work Schedule Phase-Out
Published 11 h ago3 sourcesEvidence: Reported
SeverityModerateAssessedDeveloping storyInfoMoneyBR
Markets
6.0
Inter Bank Q3 profit up 26% to R$425M, ROE 15.8%, credit growth slows
Published 1 d ago3 sourcesEvidence: Reported
SeverityModerateBrazil JournalBR